1 Supply Summary

• 1.1 Orally Administered Vaccine Introduction
• 1.2 World Orally Administered Vaccine Supply & Forecast
  • 1.2.1 World Orally Administered Vaccine Production Value (2018 & 2022 & 2029)
  • 1.2.2 World Orally Administered Vaccine Production (2018-2029)
  • 1.2.3 World Orally Administered Vaccine Pricing Trends (2018-2029)
• 1.3 World Orally Administered Vaccine Production by Region (Based on Production Site)
  • 1.3.1 World Orally Administered Vaccine Production Value by Region (2018-2029)
  • 1.3.2 World Orally Administered Vaccine Production by Region (2018-2029)
  • 1.3.3 World Orally Administered Vaccine Average Price by Region (2018-2029)
  • 1.3.4 North America Orally Administered Vaccine Production (2018-2029)
  • 1.3.5 Europe Orally Administered Vaccine Production (2018-2029)
  • 1.3.6 China Orally Administered Vaccine Production (2018-2029)
  • 1.3.7 Japan Orally Administered Vaccine Production (2018-2029)
• 1.4 Market Drivers, Restraints and Trends
  • 1.4.1 Orally Administered Vaccine Market Drivers
  • 1.4.2 Factors Affecting Demand
  • 1.4.3 Orally Administered Vaccine Major Market Trends
• 1.5 Influence of COVID-19 and Russia-Ukraine War
  • 1.5.1 Influence of COVID-19
  • 1.5.2 Influence of Russia-Ukraine War

2 Demand Summary

• 2.1 World Orally Administered Vaccine Demand (2018-2029)
• 2.2 World Orally Administered Vaccine Consumption by Region
  • 2.2.1 World Orally Administered Vaccine Consumption by Region (2018-2023)
  • 2.2.2 World Orally Administered Vaccine Consumption Forecast by Region (2024-2029)
• 2.3 United States Orally Administered Vaccine Consumption (2018-2029)
• 2.4 China Orally Administered Vaccine Consumption (2018-2029)
• 2.5 Europe Orally Administered Vaccine Consumption (2018-2029)
• 2.6 Japan Orally Administered Vaccine Consumption (2018-2029)
• 2.7 South Korea Orally Administered Vaccine Consumption (2018-2029)
• 2.8 ASEAN Orally Administered Vaccine Consumption (2018-2029)
• 2.9 India Orally Administered Vaccine Consumption (2018-2029)

3 World Orally Administered Vaccine Manufacturers Competitive Analysis

• 3.1 World Orally Administered Vaccine Production Value by Manufacturer (2018-2023)
• 3.2 World Orally Administered Vaccine Production by Manufacturer (2018-2023)
• 3.3 World Orally Administered Vaccine Average Price by Manufacturer (2018-2023)
• 3.4 Orally Administered Vaccine Company Evaluation Quadrant
• 3.5 Industry Rank and Concentration Rate (CR)
  • 3.5.1 Global Orally Administered Vaccine Industry Rank of Major Manufacturers
  • 3.5.2 Global Concentration Ratios (CR4) for Orally Administered Vaccine in 2022
  • 3.5.3 Global Concentration Ratios (CR8) for Orally Administered Vaccine in 2022
• 3.6 Orally Administered Vaccine Market: Overall Company Footprint Analysis
  • 3.6.1 Orally Administered Vaccine Market: Region Footprint
  • 3.6.2 Orally Administered Vaccine Market: Company Product Type Footprint
  • 3.6.3 Orally Administered Vaccine Market: Company Product Application Footprint
• 3.7 Competitive Environment
  • 3.7.1 Historical Structure of the Industry
  • 3.7.2 Barriers of Market Entry
  • 3.7.3 Factors of Competition
• 3.8 New Entrant and Capacity Expansion Plans
• 3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World

• 4.1 United States VS China: Orally Administered Vaccine Production Value Comparison
  • 4.1.1 United States VS China: Orally Administered Vaccine Production Value Comparison (2018 & 2022 & 2029)
  • 4.1.2 United States VS China: Orally Administered Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
• 4.2 United States VS China: Orally Administered Vaccine Production Comparison
  • 4.2.1 United States VS China: Orally Administered Vaccine Production Comparison (2018 & 2022 & 2029)
  • 4.2.2 United States VS China: Orally Administered Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
• 4.3 United States VS China: Orally Administered Vaccine Consumption Comparison
  • 4.3.1 United States VS China: Orally Administered Vaccine Consumption Comparison (2018 & 2022 & 2029)
  • 4.3.2 United States VS China: Orally Administered Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
• 4.4 United States Based Orally Administered Vaccine Manufacturers and Market Share, 2018-2023
  • 4.4.1 United States Based Orally Administered Vaccine Manufacturers, Headquarters and Production Site (States, Country)
  • 4.4.2 United States Based Manufacturers Orally Administered Vaccine Production Value (2018-2023)
  • 4.4.3 United States Based Manufacturers Orally Administered Vaccine Production (2018-2023)
• 4.5 China Based Orally Administered Vaccine Manufacturers and Market Share
  • 4.5.1 China Based Orally Administered Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
  • 4.5.2 China Based Manufacturers Orally Administered Vaccine Production Value (2018-2023)
  • 4.5.3 China Based Manufacturers Orally Administered Vaccine Production (2018-2023)
• 4.6 Rest of World Based Orally Administered Vaccine Manufacturers and Market Share, 2018-2023
  • 4.6.1 Rest of World Based Orally Administered Vaccine Manufacturers, Headquarters and Production Site (State, Country)
  • 4.6.2 Rest of World Based Manufacturers Orally Administered Vaccine Production Value (2018-2023)
  • 4.6.3 Rest of World Based Manufacturers Orally Administered Vaccine Production (2018-2023)

5 Market Analysis by Type

• 5.1 World Orally Administered Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
• 5.2 Segment Introduction by Type
  • 5.2.1 Rotavirus Vaccine
  • 5.2.2 Cholera Vaccine
  • 5.2.3 Oral Polio Vaccine
  • 5.2.4 Other
• 5.3 Market Segment by Type
  • 5.3.1 World Orally Administered Vaccine Production by Type (2018-2029)
  • 5.3.2 World Orally Administered Vaccine Production Value by Type (2018-2029)
  • 5.3.3 World Orally Administered Vaccine Average Price by Type (2018-2029)

6 Market Analysis by Application

• 6.1 World Orally Administered Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
• 6.2 Segment Introduction by Application
  • 6.2.1 Public
  • 6.2.2 Private
• 6.3 Market Segment by Application
  • 6.3.1 World Orally Administered Vaccine Production by Application (2018-2029)
  • 6.3.2 World Orally Administered Vaccine Production Value by Application (2018-2029)
  • 6.3.3 World Orally Administered Vaccine Average Price by Application (2018-2029)

7 Company Profiles

• 7.1 Merck
  • 7.1.1 Merck Details
  • 7.1.2 Merck Major Business
  • 7.1.3 Merck Orally Administered Vaccine Product and Services
  • 7.1.4 Merck Orally Administered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  • 7.1.5 Merck Recent Developments/Updates
  • 7.1.6 Merck Competitive Strengths & Weaknesses
• 7.2 GSK
  • 7.2.1 GSK Details
  • 7.2.2 GSK Major Business
  • 7.2.3 GSK Orally Administered Vaccine Product and Services
  • 7.2.4 GSK Orally Administered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  • 7.2.5 GSK Recent Developments/Updates
  • 7.2.6 GSK Competitive Strengths & Weaknesses
• 7.3 Sanofi
  • 7.3.1 Sanofi Details
  • 7.3.2 Sanofi Major Business
  • 7.3.3 Sanofi Orally Administered Vaccine Product and Services
  • 7.3.4 Sanofi Orally Administered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  • 7.3.5 Sanofi Recent Developments/Updates
  • 7.3.6 Sanofi Competitive Strengths & Weaknesses
• 7.4 Lanzhou Institute
  • 7.4.1 Lanzhou Institute Details
  • 7.4.2 Lanzhou Institute Major Business
  • 7.4.3 Lanzhou Institute Orally Administered Vaccine Product and Services
  • 7.4.4 Lanzhou Institute Orally Administered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  • 7.4.5 Lanzhou Institute Recent Developments/Updates
  • 7.4.6 Lanzhou Institute Competitive Strengths & Weaknesses
• 7.5 Serum Institute
  • 7.5.1 Serum Institute Details
  • 7.5.2 Serum Institute Major Business
  • 7.5.3 Serum Institute Orally Administered Vaccine Product and Services
  • 7.5.4 Serum Institute Orally Administered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  • 7.5.5 Serum Institute Recent Developments/Updates
  • 7.5.6 Serum Institute Competitive Strengths & Weaknesses
• 7.6 Valneva
  • 7.6.1 Valneva Details
  • 7.6.2 Valneva Major Business
  • 7.6.3 Valneva Orally Administered Vaccine Product and Services
  • 7.6.4 Valneva Orally Administered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  • 7.6.5 Valneva Recent Developments/Updates
  • 7.6.6 Valneva Competitive Strengths & Weaknesses
• 7.7 Shanghai United Cell
  • 7.7.1 Shanghai United Cell Details
  • 7.7.2 Shanghai United Cell Major Business
  • 7.7.3 Shanghai United Cell Orally Administered Vaccine Product and Services
  • 7.7.4 Shanghai United Cell Orally Administered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  • 7.7.5 Shanghai United Cell Recent Developments/Updates
  • 7.7.6 Shanghai United Cell Competitive Strengths & Weaknesses
• 7.8 Bibcol
  • 7.8.1 Bibcol Details
  • 7.8.2 Bibcol Major Business
  • 7.8.3 Bibcol Orally Administered Vaccine Product and Services
  • 7.8.4 Bibcol Orally Administered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  • 7.8.5 Bibcol Recent Developments/Updates
  • 7.8.6 Bibcol Competitive Strengths & Weaknesses
• 7.9 PaxVax
  • 7.9.1 PaxVax Details
  • 7.9.2 PaxVax Major Business
  • 7.9.3 PaxVax Orally Administered Vaccine Product and Services
  • 7.9.4 PaxVax Orally Administered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  • 7.9.5 PaxVax Recent Developments/Updates
  • 7.9.6 PaxVax Competitive Strengths & Weaknesses
• 7.10 Vabiotech
  • 7.10.1 Vabiotech Details
  • 7.10.2 Vabiotech Major Business
  • 7.10.3 Vabiotech Orally Administered Vaccine Product and Services
  • 7.10.4 Vabiotech Orally Administered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  • 7.10.5 Vabiotech Recent Developments/Updates
  • 7.10.6 Vabiotech Competitive Strengths & Weaknesses
• 7.11 Tiantan Biological
  • 7.11.1 Tiantan Biological Details
  • 7.11.2 Tiantan Biological Major Business
  • 7.11.3 Tiantan Biological Orally Administered Vaccine Product and Services
  • 7.11.4 Tiantan Biological Orally Administered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  • 7.11.5 Tiantan Biological Recent Developments/Updates
  • 7.11.6 Tiantan Biological Competitive Strengths & Weaknesses
• 7.12 EuBiologics
  • 7.12.1 EuBiologics Details
  • 7.12.2 EuBiologics Major Business
  • 7.12.3 EuBiologics Orally Administered Vaccine Product and Services
  • 7.12.4 EuBiologics Orally Administered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  • 7.12.5 EuBiologics Recent Developments/Updates
  • 7.12.6 EuBiologics Competitive Strengths & Weaknesses
• 7.13 Panacea Biotec Ltd
  • 7.13.1 Panacea Biotec Ltd Details
  • 7.13.2 Panacea Biotec Ltd Major Business
  • 7.13.3 Panacea Biotec Ltd Orally Administered Vaccine Product and Services
  • 7.13.4 Panacea Biotec Ltd Orally Administered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  • 7.13.5 Panacea Biotec Ltd Recent Developments/Updates
  • 7.13.6 Panacea Biotec Ltd Competitive Strengths & Weaknesses
• 7.14 Bio-Med
  • 7.14.1 Bio-Med Details
  • 7.14.2 Bio-Med Major Business
  • 7.14.3 Bio-Med Orally Administered Vaccine Product and Services
  • 7.14.4 Bio-Med Orally Administered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  • 7.14.5 Bio-Med Recent Developments/Updates
  • 7.14.6 Bio-Med Competitive Strengths & Weaknesses
• 7.15 Halfkin Bio-Pharmaceuticals
  • 7.15.1 Halfkin Bio-Pharmaceuticals Details
  • 7.15.2 Halfkin Bio-Pharmaceuticals Major Business
  • 7.15.3 Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Product and Services
  • 7.15.4 Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  • 7.15.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
  • 7.15.6 Halfkin Bio-Pharmaceuticals Competitive Strengths & Weaknesses

8 Industry Chain Analysis

• 8.1 Orally Administered Vaccine Industry Chain
• 8.2 Orally Administered Vaccine Upstream Analysis
  • 8.2.1 Orally Administered Vaccine Core Raw Materials
  • 8.2.2 Main Manufacturers of Orally Administered Vaccine Core Raw Materials
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis
• 8.5 Orally Administered Vaccine Production Mode
• 8.6 Orally Administered Vaccine Procurement Model
• 8.7 Orally Administered Vaccine Industry Sales Model and Sales Channels
  • 8.7.1 Orally Administered Vaccine Sales Model
  • 8.7.2 Orally Administered Vaccine Typical Customers

9 Research Findings and Conclusion

10 Appendix

• 10.1 Methodology
• 10.2 Research Process and Data Source

The global Orally Administered Vaccine market size is expected to reach $ 3783.3 million by 2029, rising at a market growth of 5.4% CAGR during the forecast period (2023-2029).
Orally administered vaccines are of interest, as they elicit both systemic and mucosal immunities, in which mucosal immunity would neutralize the mucosa invading pathogen before the onset of an infection. 
This report studies the global Orally Administered Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Orally Administered Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Orally Administered Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Orally Administered Vaccine total production and demand, 2018-2029, (K Units)
Global Orally Administered Vaccine total production value, 2018-2029, (USD Million)
Global Orally Administered Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Orally Administered Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Orally Administered Vaccine domestic production, consumption, key domestic manufacturers and share
Global Orally Administered Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Orally Administered Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Orally Administered Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Orally Administered Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol and PaxVax, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Orally Administered Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Orally Administered Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Orally Administered Vaccine Market, Segmentation by Type
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Other
Global Orally Administered Vaccine Market, Segmentation by Application
Public
Private
Companies Profiled:
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Key Questions Answered
1. How big is the global Orally Administered Vaccine market?
2. What is the demand of the global Orally Administered Vaccine market?
3. What is the year over year growth of the global Orally Administered Vaccine market?
4. What is the production and production value of the global Orally Administered Vaccine market?
5. Who are the key producers in the global Orally Administered Vaccine market?
6. What are the growth factors driving the market demand?